Jiangsu Ebitda from 2010 to 2024

688399 Stock   70.20  0.17  0.24%   
Jiangsu Bioperfectus' EBITDA is increasing over the years with slightly volatile fluctuation. Overall, EBITDA is expected to go to about 2.7 B this year. From 2010 to 2024 Jiangsu Bioperfectus EBITDA quarterly data regression line had arithmetic mean of  707,369,751 and r-squared of  0.69. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
2.6 B
Current Value
2.7 B
Quarterly Volatility
B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jiangsu Bioperfectus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jiangsu Bioperfectus' main balance sheet or income statement drivers, such as Net Interest Income of 51.3 M, Interest Expense of 7.3 M or Selling General Administrative of 275.6 M, as well as many indicators such as . Jiangsu financial statements analysis is a perfect complement when working with Jiangsu Bioperfectus Valuation or Volatility modules.
  
This module can also supplement various Jiangsu Bioperfectus Technical models . Check out the analysis of Jiangsu Bioperfectus Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Jiangsu Stock

Jiangsu Bioperfectus financial ratios help investors to determine whether Jiangsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jiangsu with respect to the benefits of owning Jiangsu Bioperfectus security.